129 related articles for article (PubMed ID: 34382511)
81. FTY720-induced enhancement of autophagy protects cells from FTY720 cytotoxicity in colorectal cancer.
Li J; Wang SW; Zhang DS; Sun Y; Zhu CY; Fei Q; Hu J; Zhang C; Sun YM
Oncol Rep; 2016 May; 35(5):2833-42. PubMed ID: 26985637
[TBL] [Abstract][Full Text] [Related]
82. Ceramide produces apoptosis through induction of p27(kip1) by protein phosphatase 2A-dependent Akt dephosphorylation in PC-3 prostate cancer cells.
Kim SW; Kim HJ; Chun YJ; Kim MY
J Toxicol Environ Health A; 2010; 73(21-22):1465-76. PubMed ID: 20954073
[TBL] [Abstract][Full Text] [Related]
83. Stool-fermented Plantago ovata husk induces apoptosis in colorectal cancer cells independently of molecular phenotype.
Sohn VR; Giros A; Xicola RM; Fluvià L; Grzybowski M; Anguera A; Llor X
Br J Nutr; 2012 Jun; 107(11):1591-602. PubMed ID: 22018732
[TBL] [Abstract][Full Text] [Related]
84. Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages.
Hammad SM; Crellin HG; Wu BX; Melton J; Anelli V; Obeid LM
Prostaglandins Other Lipid Mediat; 2008 Mar; 85(3-4):107-14. PubMed ID: 18166496
[TBL] [Abstract][Full Text] [Related]
85. Mitochondrially targeted ceramide LCL-30 inhibits colorectal cancer in mice.
Dahm F; Bielawska A; Nocito A; Georgiev P; Szulc ZM; Bielawski J; Jochum W; Dindo D; Hannun YA; Clavien PA
Br J Cancer; 2008 Jan; 98(1):98-105. PubMed ID: 18026195
[TBL] [Abstract][Full Text] [Related]
86. Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma.
Chen MH; Yen CC; Cheng CT; Wu RC; Huang SC; Yu CS; Chung YH; Liu CY; Chang PM; Chao Y; Chen MH; Chen YF; Chiang KC; Yeh TS; Chen TC; Huang CY; Yeh CN
Oncotarget; 2015 Sep; 6(27):23594-608. PubMed ID: 26090720
[TBL] [Abstract][Full Text] [Related]
87. Combination of targeting CD24 and inhibiting autophagy suppresses the proliferation and enhances the apoptosis of colorectal cancer cells.
Zhuo J; Wang X
Mol Med Rep; 2019 Jul; 20(1):539-548. PubMed ID: 31180548
[TBL] [Abstract][Full Text] [Related]
88. The sphingosine kinase inhibitor 2-(p-hyroxyanilino)-4-(p-chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress-dependent mechanism.
Tonelli F; Alossaimi M; Williamson L; Tate RJ; Watson DG; Chan E; Bittman R; Pyne NJ; Pyne S
Br J Pharmacol; 2013 Mar; 168(6):1497-505. PubMed ID: 23113536
[TBL] [Abstract][Full Text] [Related]
89. Knockdown of GRHL2 inhibited proliferation and induced apoptosis of colorectal cancer by suppressing the PI3K/Akt pathway.
Hu F; He Z; Sun C; Rong D
Gene; 2019 Jun; 700():96-104. PubMed ID: 30917932
[TBL] [Abstract][Full Text] [Related]
90. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer.
Abdalla AN; Malki WH; Qattan A; Shahid I; Hossain MA; Ahmed M
Molecules; 2021 Jan; 26(2):. PubMed ID: 33440689
[TBL] [Abstract][Full Text] [Related]
91. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.
Nagahashi M; Ramachandran S; Kim EY; Allegood JC; Rashid OM; Yamada A; Zhao R; Milstien S; Zhou H; Spiegel S; Takabe K
Cancer Res; 2012 Feb; 72(3):726-35. PubMed ID: 22298596
[TBL] [Abstract][Full Text] [Related]
92. AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms.
Zhang S; Deng Z; Yao C; Huang P; Zhang Y; Cao S; Li X
PLoS One; 2017; 12(1):e0169585. PubMed ID: 28081222
[TBL] [Abstract][Full Text] [Related]
93. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression.
Ishitsuka A; Fujine E; Mizutani Y; Tawada C; Kanoh H; Banno Y; Seishima M
Int J Mol Med; 2014 Oct; 34(4):1169-74. PubMed ID: 25109763
[TBL] [Abstract][Full Text] [Related]
94. Molecular docking analysis of sphingosine kinase 1 inhibitors for cancer management.
Barnawi J
Bioinformation; 2023; 19(5):571-576. PubMed ID: 37886152
[TBL] [Abstract][Full Text] [Related]
95. Discovery of a Novel Series of
Zhang J; Qiu Z; Liu S; Huang J; Luo B; Sui J; Dai Z; Xiang X; Yang T; Luo Y
J Med Chem; 2024 Feb; 67(4):2812-2836. PubMed ID: 38329974
[No Abstract] [Full Text] [Related]
96. Antioral Cancer Effects by the Nitrated [6,6,6]Tricycles Compound (SK1) In Vitro.
Chen YN; Chan CK; Yen CY; Shiau JP; Chang MY; Wang CC; Jeng JH; Tang JY; Chang HW
Antioxidants (Basel); 2022 Oct; 11(10):. PubMed ID: 36290795
[TBL] [Abstract][Full Text] [Related]
97. Investigation of the Effects of Apigenin, a Possible Therapeutic Agent, on Cytotoxic and SWH Pathway in Colorectal Cancer (HT29) Cells.
Cicek M; Unsal V; Emre A; Doganer A
Adv Pharm Bull; 2023 Jan; 13(1):188-195. PubMed ID: 36721804
[No Abstract] [Full Text] [Related]
98. Design, synthesis and analysis of novel sphingosine kinase-1 inhibitors to improve oral bioavailability.
Butler KJ; Castro AA; Dwyer TS; Hardwick LM; Iacino MC; Manore SG; Mays KM; McGlade CA; Hair LN; Parker EW; Smith MR; Turnow MT; Wilson MR; Woodson SR; Cotham WE; Walla MD; Hurlbert JC; Christian Grattan T
Bioorg Med Chem Lett; 2021 Oct; 50():128329. PubMed ID: 34418572
[TBL] [Abstract][Full Text] [Related]
99. Sphingosine kinase 2 is essential for remyelination following cuprizone intoxication.
Song H; McEwen HP; Duncan T; Lee JY; Teo JD; Don AS
Glia; 2021 Dec; 69(12):2863-2881. PubMed ID: 34399014
[TBL] [Abstract][Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
